Differentiation therapy with progesterone antagonists.
Michna
H
H
Research Laboratories of Schering AG, Berlin, Germany.
Parczyk
K
K
Schneider
M R
MR
Nishino
Y
Y
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001943:Breast Neoplasms / Q000188:drug therapy; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D004967:Estrogens / Q000502:physiology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D011372:Progestins / Q000037:antagonists & inhibitors*; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011980:Receptors, Progesterone / Q000037:antagonists & inhibitors / Q000502:physiology; D015533:Transcriptional Activation / Q000187:drug effects; D014599:Uterus / Q000166:cytology / Q000187:drug effects
D000970:Antineoplastic Agents; D004967:Estrogens; D011372:Progestins; D011980:Receptors, Progesterone